Three-Gene Immunohistochemical Panel Adds to Clinical Staging Algorithms to Predict Prognosis for Patients With Esophageal Adenocarcinoma

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

OC-017 TRIM44: from prognosis to therapy in oesophageal adenocarcinoma and breast cancer

(2012) C A J Ong et al.   GUT

SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity

(2011) Hyun-Seok Kim et al.   CANCER CELL

Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma

(2011) X. Y. Goh et al.   GUT

Esophageal Cancer: A Critical Evaluation of Systemic Second-Line Therapy

(2011) Christiane Maria Rosina Thallinger et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis

(2011) Katrin M Sjoquist et al.   LANCET ONCOLOGY

Targeting the human EGFR family in esophagogastric cancer

(2011) Alicia Okines et al.   Nature Reviews Clinical Oncology

Targeted therapies: how personal should we go?

(2011) Miriam Martini et al.   Nature Reviews Clinical Oncology

Aurora kinase inhibitors as anticancer molecules

(2010) Hiroshi Katayama et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Esophageal Adenocarcinoma Incidence: Are We Reaching the Peak?

(2010) H. Pohl et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of ENMD-2076, a Novel Angiogenic and Aurora Kinase Inhibitor,in Patients with Advanced Solid Tumors

(2010) J. R. Diamond et al.   CLINICAL CANCER RESEARCH

Esophageal Adenocarcinoma: Treatment Modalities in the Era of Targeted Therapy

(2010) Kaushik Mukherjee et al.   DIGESTIVE DISEASES AND SCIENCES

A 4-Gene Signature Predicts Survival of Patients With Resected Adenocarcinoma of the Esophagus, Junction, and Gastric Cardia

(2010) Christopher J. Peters et al.   GASTROENTEROLOGY

HER2and Chromosome 17 Effect on Patient Outcome in the N9831 Adjuvant Trastuzumab Trial

(2010) Edith A. Perez et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome

(2010) Soo Mi Kim et al.   PLoS One

Biomarkers in Barrett’s esophagus and esophageal adenocarcinoma: Predictors of progression and prognosis

(2010) Chin-Ann J Ong   WORLD JOURNAL OF GASTROENTEROLOGY

TRIM44 interacts with and stabilizes terf, a TRIM ubiquitin E3 ligase

(2009) Tomohiko Urano et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Surgical specialty, surgical unit volume and mortality after oesophageal cancer surgery

(2009) Y. Leigh et al.   EJSO

Cell cycle kinases as therapeutic targets for cancer

(2009) Silvia Lapenna et al.   NATURE REVIEWS DRUG DISCOVERY

Predicting Individual Survival After Potentially Curative Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction

(2008) Sjoerd M. Lagarde et al.   ANNALS OF SURGERY

Targeted therapy for oesophageal cancer: an overview

(2008) K. N. Syrigos et al.   CANCER AND METASTASIS REVIEWS

Clinical Application of the 70-Gene Profile: The MINDACT Trial

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY